Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.07
AIQ's Cash to Debt is ranked lower than
57% of the 181 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 10.63 vs. AIQ: 0.07 )
AIQ' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.07

Equity to Asset -0.38
AIQ's Equity to Asset is ranked lower than
58% of the 167 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.68 vs. AIQ: -0.38 )
AIQ' s 10-Year Equity to Asset Range
Min: -0.38   Max: 0.16
Current: -0.38

-0.38
0.16
F-Score: 5
Z-Score: 0.36
M-Score: -3.56
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -5.90
AIQ's Operating margin (%) is ranked higher than
63% of the 174 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.31 vs. AIQ: -5.90 )
AIQ' s 10-Year Operating margin (%) Range
Min: -39.88   Max: 26.28
Current: -5.9

-39.88
26.28
Net-margin (%) -4.79
AIQ's Net-margin (%) is ranked higher than
63% of the 174 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.95 vs. AIQ: -4.79 )
AIQ' s 10-Year Net-margin (%) Range
Min: -32.43   Max: 18.69
Current: -4.79

-32.43
18.69
ROA (%) -4.39
AIQ's ROA (%) is ranked higher than
64% of the 180 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.07 vs. AIQ: -4.39 )
AIQ' s 10-Year ROA (%) Range
Min: -24.15   Max: 9.96
Current: -4.39

-24.15
9.96
ROC (Joel Greenblatt) (%) -12.67
AIQ's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 179 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 5.52 vs. AIQ: -12.67 )
AIQ' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -65.14   Max: 29.18
Current: -12.67

-65.14
29.18
Revenue Growth (%) -2.40
AIQ's Revenue Growth (%) is ranked higher than
64% of the 134 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 7.90 vs. AIQ: -2.40 )
AIQ' s 10-Year Revenue Growth (%) Range
Min: -2.8   Max: 27
Current: -2.4

-2.8
27
EBITDA Growth (%) -4.40
AIQ's EBITDA Growth (%) is ranked higher than
66% of the 114 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 6.00 vs. AIQ: -4.40 )
AIQ' s 10-Year EBITDA Growth (%) Range
Min: -20.5   Max: 151.9
Current: -4.4

-20.5
151.9
EPS Growth (%) -13.20
AIQ's EPS Growth (%) is ranked higher than
62% of the 110 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.30 vs. AIQ: -13.20 )
AIQ' s 10-Year EPS Growth (%) Range
Min: -70   Max: 122.4
Current: -13.2

-70
122.4
» AIQ's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

AIQ Guru Trades in Q1 2013

Jim Simons 85,060 sh (New)
Howard Marks 4,756,490 sh (New)
» More
Q2 2013

AIQ Guru Trades in Q2 2013

Jim Simons 133,260 sh (+56.67%)
Howard Marks 4,756,490 sh (unchged)
» More
Q3 2013

AIQ Guru Trades in Q3 2013

Jim Simons 433,160 sh (+225.05%)
Howard Marks 4,756,490 sh (unchged)
» More
Q4 2013

AIQ Guru Trades in Q4 2013

Jim Simons 442,560 sh (+2.17%)
Howard Marks 4,756,490 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with AIQ



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.70
AIQ's P/S is ranked higher than
92% of the 172 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.63 vs. AIQ: 0.70 )
AIQ' s 10-Year P/S Range
Min: 0.08   Max: 1.54
Current: 0.7

0.08
1.54
PFCF 5.10
AIQ's PFCF is ranked higher than
95% of the 80 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.36 vs. AIQ: 5.10 )
AIQ' s 10-Year PFCF Range
Min: 0.74   Max: 28.19
Current: 5.1

0.74
28.19
EV-to-EBIT 100.00
AIQ's EV-to-EBIT is ranked lower than
80% of the 122 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 21.08 vs. AIQ: 100.00 )
AIQ' s 10-Year EV-to-EBIT Range
Min: 7.5   Max: 25.2
Current: 100

7.5
25.2

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.00
AIQ's Price/DCF (Projected) is ranked higher than
81% of the 80 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.70 vs. AIQ: 1.00 )
AIQ' s 10-Year Price/DCF (Projected) Range
Min: 0.22   Max: 1.56
Current: 1

0.22
1.56
Price/Median PS Value 1.10
AIQ's Price/Median PS Value is ranked higher than
67% of the 159 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.10 vs. AIQ: 1.10 )
AIQ' s 10-Year Price/Median PS Value Range
Min: 0.23   Max: 2.4
Current: 1.1

0.23
2.4
Earnings Yield (Greenblatt) 1.00
AIQ's Earnings Yield (Greenblatt) is ranked lower than
66% of the 120 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.70 vs. AIQ: 1.00 )
AIQ' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1   Max: 13.3
Current: 1

1
13.3
Forward Rate of Return (Yacktman) 15.41
AIQ's Forward Rate of Return (Yacktman) is ranked higher than
92% of the 138 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.42 vs. AIQ: 15.41 )
AIQ' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.6   Max: 24.8
Current: 15.41

3.6
24.8

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research
Compare:LH, ALR, DGX, LIFE, ENZ » details
Traded in other countries:AI6M.Germany
Alliance HealthCare Services Inc was incorporated in the state of Delaware on May 27, 1987. The Company, together with its subsidiaries, provides outpatient diagnostic imaging and radiation therapy services in the United States. Its diagnostic imaging services include magnetic resonance imaging technology and positron emission tomography/computed tomography services that generate representations of the internal anatomy and convert them to film or digital media. It also offers non scan-based services, which comprise the use of imaging systems under a short-term contract. In addition, it provides radiation oncology services that include conventional beam therapy, 3-D conformal radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, stereotactic radiosurgery, low dose rate brachytherapy, and high dose rate brachytherapy for the treatment of cancer; and stereotactic radiation oncology services. Further, the Company offers ancillary services, such as marketing support, education, training, and billing assistance. It provides imaging and therapeutic services through hospitals and clinics, independent imaging and radiation oncology centers, and other healthcare providers on a shared-service and full-time service basis, as well as provides services through fixed-sites, primarily to hospitals or health systems.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

Capvyce
ReplyCapvyce - 1 month ago
d

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide